<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Infect Chemother</journal-id>
      <journal-id journal-id-type="iso-abbrev">J. Infect. Chemother</journal-id>
      <journal-title-group>
        <journal-title>Journal of Infection and Chemotherapy</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1341-321X</issn>
      <issn pub-type="epub">1437-7780</issn>
      <publisher>
        <publisher-name>Springer Japan</publisher-name>
        <publisher-loc>Tokyo</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23354937</article-id>
      <article-id pub-id-type="pmc">3824296</article-id>
      <article-id pub-id-type="publisher-id">558</article-id>
      <article-id pub-id-type="doi">10.1007/s10156-013-0558-0</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Systemic inflammatory response syndrome and prolonged hypoperfusion lesions in an infant with respiratory syncytial virus encephalopathy</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Miyamoto</surname>
            <given-names>Kenji</given-names>
          </name>
          <address>
            <email>kenmimi@dokkyomed.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fujisawa</surname>
            <given-names>Masahide</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hozumi</surname>
            <given-names>Hajime</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tsuboi</surname>
            <given-names>Tatsuo</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kuwashima</surname>
            <given-names>Shigeko</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hirao</surname>
            <given-names>Jun-ichi</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sugita</surname>
            <given-names>Kenichi</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Arisaka</surname>
            <given-names>Osamu</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Pediatrics, Dokkyo Medical University, 880 Kitakobayashi, Mibu-machi, Shimotsuga, Tochigi, 321-0293 Japan </aff>
        <aff id="Aff2"><label/>Department of Radiology, Dokkyo Medical University, Tochigi, Japan </aff>
        <aff id="Aff3"><label/>Clinical Training Center, Dokkyo Medical University, Tochigi, Japan </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>26</day>
        <month>1</month>
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>26</day>
        <month>1</month>
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <year>2013</year>
      </pub-date>
      <volume>19</volume>
      <issue>5</issue>
      <fpage>978</fpage>
      <lpage>982</lpage>
      <history>
        <date date-type="received">
          <day>17</day>
          <month>8</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>9</day>
          <month>1</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2013</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <p>Respiratory syncytial virus (RSV) is a cause of neurological complications in infants. We report a rare case of RSV encephalopathy in an infant who presented with poor sucking and hypothermia at 17&#xA0;days of age after suffering from rhinorrhea and a cough for several days. After hospitalization, the patient presented with stupor and hypotonia lasting for at least 24&#xA0;h, and was intubated, sedated, and ventilated for treatment of pneumonia. These symptoms led to diagnosis of pediatric systemic inflammatory response syndrome (SIRS) caused by RSV infection. High-dose steroid therapy was combined with artificial ventilation because the initial ventilation therapy was ineffective. Interleukin (IL)-6 levels in spinal fluid were markedly increased upon admission, and serum IL-6 and IL-8 levels showed even greater elevation. The patient was diagnosed with RSV encephalopathy. On day 5, high signal intensity in the bilateral hippocampus was observed on diffusion-weighted magnetic resonance imaging (MRI). On day 14, the patient presented with delayed partial seizure and an electroencephalogram showed occasional unilateral spikes in the parietal area, but the hippocampal abnormality had improved to normal on MRI. <sup>99m</sup>Tc-labeled ethylcysteinate dimer single-photon emission computed tomography (SPECT) on day 18 showed hypoperfusion of the bilateral frontal and parietal regions and the unilateral temporal region. SPECT at 3&#xA0;months after onset still showed hypoperfusion of the bilateral frontal region and unilateral temporal region, but hypoperfusion of the bilateral parietal region had improved. The patient has no neurological deficit at 6&#xA0;months. These findings suggest that RSV encephalopathy with cytokine storm induces several symptoms and complications, including SIRS and prolonged brain hypoperfusion on SPECT.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Respiratory syncytial virus</kwd>
        <kwd>Encephalopathy</kwd>
        <kwd>Cytokine</kwd>
        <kwd>Infant</kwd>
        <kwd>Single-photon emission computed tomography</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases 2013</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="intro">
      <title>Introduction</title>
      <p>Infection with respiratory syncytial virus (RSV) causes bronchitis, bronchiolitis, and pneumonia, and leads to neurological complications in 1.8&#xA0;% of cases [<xref ref-type="bibr" rid="CR1">1</xref>]. These neurological complications include RSV encephalopathy [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>], the cause of which remains unclear. Kawashima et al. [<xref ref-type="bibr" rid="CR4">4</xref>] defined three pathogenic types of RSV encephalopathy characterized by metabolic error, excitotoxicity, and cytokine storm. Here, we describe a rare case of a neonate with RSV encephalopathy of the cytokine storm type, which involved development of pediatric systemic inflammatory response syndrome (SIRS) and prolonged hypoperfusion lesions on brain single-photon emission computed tomography (SPECT) without neurological sequelae.</p>
    </sec>
    <sec id="Sec2">
      <title>Case report</title>
      <p>The patient was a male infant born at 39&#xA0;weeks gestation (birth weight, 3,562&#xA0;g). At this time, his brother and cousin both had a cold, and the patient presented with rhinorrhea and cough after several days. At 17&#xA0;days of age, his parents brought him to the emergency department because of poor sucking for more than half a day and hypothermia (33.0&#xA0;&#xB0;C). The patient was in a continuous stupor with hypotonia and did not respond to pain. He presented with cyanosis, and percutaneous oxygen saturation was 86&#xA0;%. The desaturation was reversed by oxygenation. After hospitalization, a physical examination showed wheezes and hepatomegaly. Respiratory therapy with nasal continuous positive airway pressure was started, but apnea persisted.</p>
      <p>Laboratory findings upon admission showed increased aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactase dehydrogenase (LDH), creatine phosphokinase (CPK), and carbon dioxide (PaCO<sub>2</sub>) (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>). AST, ALT, LDH, and CPK levels in serum increased progressively until day 2. RSV antigen was detected in a nasopharyngeal swab. The results of several cultures were negative. Chest radiography and computed tomography scans showed bilateral pulmonary infiltrative shadow, atelectasis, and severe air trapping. A diagnosis of pediatric SIRS caused by RSV infection was made based on the published criteria for this condition [<xref ref-type="bibr" rid="CR5">5</xref>].<table-wrap id="Tab1"><label>Table&#xA0;1</label><caption><p>Laboratory data at admission</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" colspan="2">Peripheral blood</td><td align="left" colspan="2">Arterial blood gas analysis (FiO<sub>2</sub> 0.30&#x2013;0.45)</td></tr><tr><td align="left">&#xA0;WBC</td><td align="left">20,200/&#x3BC;l</td><td align="left">&#xA0;pH</td><td align="left">7.228</td></tr><tr><td align="left">&#xA0;&#xA0;Nt</td><td char="." align="left">31&#xA0;%</td><td align="left">&#xA0;PaCO<sub>2</sub>
</td><td align="left">69.4&#xA0;Torr</td></tr><tr><td align="left">&#xA0;&#xA0;Ly</td><td char="." align="left">47&#xA0;%</td><td align="left">&#xA0;PaO<sub>2</sub>
</td><td align="left">72.7&#xA0;Torr</td></tr><tr><td align="left">&#xA0;&#xA0;Mo</td><td char="." align="left">10&#xA0;%</td><td align="left">&#xA0;HCO<sub>3</sub>
<sup>&#x2212;</sup>
</td><td align="left">27.9&#xA0;mmol/l</td></tr><tr><td align="left">&#xA0;&#xA0;Eo</td><td char="." align="left">2&#xA0;%</td><td align="left">&#xA0;BE</td><td align="left">&#x2212;0.1&#xA0;mEq/l</td></tr><tr><td align="left">&#xA0;&#xA0;Ba</td><td char="." align="left">0&#xA0;%</td><td align="left" colspan="2">Serology</td></tr><tr><td align="left">&#xA0;RBC</td><td char="&#xD7;" align="left">305&#xA0;&#xD7;&#xA0;10<sup>4</sup>/&#x3BC;l</td><td align="left">&#xA0;CRP</td><td align="left">3.87&#xA0;mg/dl</td></tr><tr><td align="left">&#xA0;&#xA0;Hb</td><td align="left">10.1&#xA0;g/dl</td><td align="left">&#xA0;Procalcitonin</td><td align="left">0.77&#xA0;ng/ml</td></tr><tr><td align="left">&#xA0;&#xA0;Ht</td><td char="." align="left">32.4&#xA0;%</td><td align="left">&#xA0;IgG</td><td align="left">853&#xA0;mg/dl</td></tr><tr><td align="left">&#xA0;&#xA0;Plt</td><td char="&#xD7;" align="left">52.7&#xA0;&#xD7;&#xA0;10<sup>4</sup>/&#x3BC;l</td><td align="left">&#xA0;IgM</td><td align="left">32&#xA0;mg/dl</td></tr><tr><td align="left" colspan="2">Biochemistry</td><td align="left">&#xA0;IgA</td><td align="left">5&#xA0;mg/dl</td></tr><tr><td align="left">&#xA0;TP</td><td align="left">6.7&#xA0;g/dl</td><td align="left">&#xA0;Ferritin</td><td align="left">8163&#xA0;ng/ml</td></tr><tr><td align="left">&#xA0;Alb</td><td align="left">4.1&#xA0;g/dl</td><td align="left">&#xA0;IL-6 (&lt;4&#xA0;pg/ml)<sup>a</sup>
</td><td align="left">304&#xA0;pg/ml</td></tr><tr><td align="left">&#xA0;AST</td><td align="left">192&#xA0;U/l</td><td align="left" colspan="2">Serology during hospitalization</td></tr><tr><td align="left">&#xA0;ALT</td><td align="left">160&#xA0;U/l</td><td align="left">&#xA0;IL-1&#x3B2; (&lt;10&#xA0;pg/ml)<sup>a</sup>
</td><td align="left">&lt;200&#xA0;pg/ml</td></tr><tr><td align="left">&#xA0;T-bil</td><td align="left">1.3&#xA0;mg/dl</td><td align="left">&#xA0;IL-8 (&lt;2&#xA0;pg/ml)<sup>a</sup>
</td><td align="left">115&#xA0;pg/ml</td></tr><tr><td align="left">&#xA0;LDH</td><td align="left">1359&#xA0;U/l</td><td align="left">&#xA0;IL-10 (&lt;5&#xA0;pg/ml)<sup>a</sup>
</td><td align="left">&lt;20&#xA0;pg/ml</td></tr><tr><td align="left">&#xA0;CK</td><td align="left">439&#xA0;U/l</td><td align="left">&#xA0;MCP-1 (200&#x2013;722&#xA0;pg/ml)<sup>a</sup>
</td><td align="left">&lt;625&#xA0;pg/ml</td></tr><tr><td align="left">&#xA0;BUN</td><td align="left">12&#xA0;mg/dl</td><td align="left">&#xA0;TNF-&#x3B1; (0.6&#x2013;2.8&#xA0;pg/ml)<sup>a</sup>
</td><td align="left">&lt;5&#xA0;pg/ml</td></tr><tr><td align="left">&#xA0;Cre</td><td align="left">0.24&#xA0;mg/dl</td><td align="left" colspan="2">Cerebral spinal fluid</td></tr><tr><td align="left">&#xA0;Na</td><td align="left">122&#xA0;mEq/l</td><td align="left">&#xA0;IL-6 (&lt;0.4&#xA0;pg/ml)<sup>a</sup>
</td><td align="left">102&#xA0;pg/ml</td></tr><tr><td align="left">&#xA0;K</td><td align="left">5.8&#xA0;mEq/l</td><td align="left">&#xA0;Viral culture</td><td align="left">(&#x2013;)</td></tr><tr><td align="left">&#xA0;Cl</td><td align="left">89&#xA0;mEq/l</td><td align="left">&#xA0;Protein</td><td align="left">88&#xA0;mg/dl</td></tr><tr><td align="left">&#xA0;Glucose</td><td align="left">55&#xA0;g/dl</td><td align="left">&#xA0;Cell count</td><td align="left">2/&#x3BC;l</td></tr><tr><td align="left" colspan="2">Culture</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td></tr><tr><td align="left">&#xA0;Blood</td><td align="left">(&#x2013;)</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td></tr><tr><td align="left">&#xA0;Spinal fluid</td><td align="left">(&#x2013;)</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td></tr><tr><td align="left">&#xA0;Nasal</td><td align="left">
<italic>Haemophilus influenzae</italic>
</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup>Normal value or range. IL-6 was measured using Human IL-6 CLEIA (Fujirebio, Japan). IL-1&#x3B2;, IL-8, and IL-10 were measured using BIOSOURCE IL-1&#x3B2;, IL-8, and IL-10 ELISA kits (BioSource Europe, Nivelles, Belgium). MCP-1 and TNF-&#x3B1; were measured using Human MCP-1 and TNF-&#x3B1; Immunoassay kits (R&amp;D Systems, Minneapolis, MN, USA)</p></table-wrap-foot></table-wrap></p>
      <p>The patient was intubated and ventilated immediately. Profound sedation was used because high-pressure mechanical ventilation was required. Immunomodulatory therapy with high-dose steroids (methylprednisolone 30&#xA0;mg/kg/day for 3&#xA0;days) was also initiated because the respiratory therapies were ineffective. On day 5, there were no significant abnormalities on T<sub>1</sub>-weighted, T<sub>2</sub>-weighted, and fluid-attenuated inversion recovery magnetic resonance imaging (MRI), but the bilateral hippocampus showed a high signal intensity in diffusion-weighted imaging (DWI) MRI with reduction of the apparent diffusion coefficient (ADC) (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref> a, b). An electroencephalogram (EEG) was normal on day 5. The patient was extubated on day 7.<fig id="Fig1"><label>Fig.&#xA0;1</label><caption><p>Magnetic resonance imaging (MRI) on day 6. Diffusion-weighted imaging (DWI) (<bold>a</bold>) revealed bilateral high-intensity regions in the hippocampus, and the apparent diffusion coefficient (ADC) (<bold>b</bold>) was low in the same regions. <bold>c</bold>&#x2013;<bold>f</bold>
<sup>99m</sup>Tc- ethylcysteinate dimer (ECD) single-photon emission computed tomography (SPECT). Axial views through the parietal lobes (<bold>c</bold>, <bold>e</bold>) and through the cerebral cortex, white matter, and basal ganglia (<bold>d</bold>, <bold>f</bold>). <italic>Upper row</italic> (<bold>c</bold>, <bold>d</bold>): At 18&#xA0;days after onset (hospital day 18), SPECT showed hypoperfusion of the bilateral frontal and parietal lobes and the unilateral temporal lobe with some predominance on the left side. <italic>Lower row</italic> (<bold>e</bold>, <bold>f</bold>): At 3&#xA0;months after onset, hypoperfusion of the bilateral parietal lobes on SPECT had improved, but hypoperfusion of the unilateral temporal lobe with some predominance on the left side was exacerbated</p></caption><graphic xlink:href="10156_2013_558_Fig1_HTML" id="MO1"/></fig></p>
      <p>On day 14, the hippocampal abnormality and ADC were improved on DWI MRI. However, on the same day, the patient presented with trembling of the upper limbs from side to side, and an EEG showed occasional unilateral spikes in the parietal area. Therefore, anticonvulsant therapy with phenobarbital was started. Serological tests for rubella, measles, cytomegalovirus, Epstein&#x2013;Barr virus, herpes simplex virus, and autoantibodies associated with limbic encephalitis (antibodies against the glutamate receptor Glu&#x3B5;2, voltage-gated potassium channel, and NR1/NR2 subunits of the <italic>N</italic>-methyl-<sc>d</sc>-aspartate receptor) were negative during the acute phase. RSV antibody in serum was positive (NT &#xD7;16) on day 3. His mother had no ovarian teratoma during pregnancy.</p>
      <p>At admission, interleukin (IL)-6 was increased markedly in the spinal fluid, and IL-6 serum levels were even more elevated compared with the spinal fluid [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. In the acute phase, serum IL-8 was significantly and markedly increased, but IL-1&#x3B2;, IL-10, monocyte chemoattractant protein (MCP)-1, and tumor necrosis factor (TNF)-&#x3B1; levels were only slightly increased or not significantly altered (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>). Therefore, the patient was diagnosed with encephalopathy caused by RSV infection, as suggested by a prior study showing stupor and hypotonia lasting for at least 24&#xA0;h and seizure [<xref ref-type="bibr" rid="CR6">6</xref>]. <sup>99m</sup>Tc-labeled ethylcysteinate dimer (ECD) SPECT on hospital day 18 showed hypoperfusion of the bilateral frontal and parietal regions and the unilateral temporal region with some predominance on the left side (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>c, d).</p>
      <p>Follow-up EEG, MRI, and SPECT were performed 3&#xA0;months after onset. EEG was normal and phenobarbital treatment was ended. MRI did not show any signs of atrophy. <sup>99m</sup>Tc-labeled ECD SPECT at 3&#xA0;months still showed hypoperfusion of the bilateral frontal region and unilateral temporal region with some predominance on the left side. Hypoperfusion on SPECT had improved in the bilateral parietal lobes but persisted in the frontal and temporal regions (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>e, f). The patient has no neurological deficit at 6&#xA0;months of age.</p>
    </sec>
    <sec id="Sec3" sec-type="discussion">
      <title>Discussion</title>
      <p>The present case was diagnosed as RSV encephalopathy accompanied by markedly increased levels of serum IL-6. These findings are consistent with alteration of cytokine levels in influenza virus-associated encephalopathy, because previous studies have shown marked increases of IL-6 in serum and spinal fluid in this disease [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. In particular, the serum IL-6 level has been suggested to be a useful indicator for the diagnosis and clinical severity of viral encephalopathy [<xref ref-type="bibr" rid="CR7">7</xref>]. In our case, spinal fluid IL-6 was increased significantly and serum IL-6 showed an even greater increase. However, we also note that some studies have not found increased serum IL-6 in RSV encephalopathy [<xref ref-type="bibr" rid="CR2">2</xref>&#x2013;<xref ref-type="bibr" rid="CR4">4</xref>].</p>
      <p>Our observations in this case indicate that RSV encephalopathy can occur during SIRS. The cause of SIRS is essentially overproduction of inflammatory cytokines such as TNF-&#x3B1;, IL-1&#x3B2;, and IL-6 [<xref ref-type="bibr" rid="CR9">9</xref>]. Thus, SIRS associated with RSV infection may be characterized by progression of severe pneumonia caused by hematogenous actions of elevated IL-6 on the lung and encephalopathy of the cytokine storm type resulting from similar actions of IL-6 on the brain. This suggestion is supported by the marked increase in serum IL-8, which is similar to the cytokine storm that can occur in influenza virus-associated encephalopathy [<xref ref-type="bibr" rid="CR10">10</xref>]. The elevated IL-6 levels in the spinal fluid and serum and elevated IL-8 levels in the serum suggest that cytokine storm may be involved in the pathogenesis of RSV encephalopathy. However, the etiology of RSV encephalopathy is unclear. Specifically, it is uncertain whether direct impairment of the central nervous system is primarily responsible for the cerebral involvement in RSV disease, or if this is caused by increased production of one or more cytokines in cerebrospinal fluid during the acute phase [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>].</p>
      <p>The characteristics of brain imaging findings in RSV encephalopathy are also unclear. A recent report showed that these findings often include unilateral brain hemisphere abnormalities on CT, MRI, and SPECT [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. Our case exhibited hypoperfusion of the bilateral hippocampal regions and the unilateral temporal region on SPECT. In general, limbic encephalitis associated with infection is most commonly caused by herpes simplex virus, but a test for herpes simplex virus IgM antibody was negative on day 12. Most cases of autoimmune limbic encephalitis are indicated by autoantibodies, but in this case these autoantibodies were negative or normal in the acute phase [<xref ref-type="bibr" rid="CR14">14</xref>]. F&#xF6;rster et al. showed that hippocampal DWI hyperintensities and a reduction of ADC on MRI were caused by limbic encephalitis with viral infection. These infections included human herpesvirus 6 and herpes simplex virus, but not RSV [<xref ref-type="bibr" rid="CR15">15</xref>]. Therefore, this patient was diagnosed with RSV encephalopathy without limbic encephalitis.</p>
      <p>After 3&#xA0;months, hypoperfusion on SPECT had improved in the bilateral parietal lobes, but persisted in the frontal and temporal regions without neurological sequelae. Similarly, Hirayama et al. [<xref ref-type="bibr" rid="CR16">16</xref>] found that residual cerebellar abnormalities on SPECT persisted 1&#xA0;year after onset in RSV encephalitis with mild ataxia. Thus, RSV encephalopathy may be associated with prolonged cerebral hypoperfusion. Our case suggests that detection of severe RSV infection should lead to consideration of an early diagnosis of encephalopathy associated with SIRS.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p>We thank Dr. Osamu Watanabe, Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, for measurement of antibodies to the voltage-gated potassium channel; Dr. Yukitoshi Takahashi, National Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders, for measurement of antibodies to the glutamate receptor Glu&#x3B5;2; Dr. Keiko Tanaka, Department of Neurology, Kanazawa Medical University, for measurement of antibodies to the NR1/NR2 subunits of <italic>N</italic>-methyl-D-aspartate receptor; and Dr. Hidemitsu Kurosawa, Department of Pediatrics, Dokkyo Medical University, for his helpful comments on the therapy.</p>
      <sec id="d30e876">
        <title>Conflict of interest</title>
        <p>The authors declare no conflicts of interest.</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ng</surname>
              <given-names>YT</given-names>
            </name>
            <name>
              <surname>Cox</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Atkins</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Butler</surname>
              <given-names>IJ</given-names>
            </name>
          </person-group>
          <article-title>Encephalopathy associated with respiratory syncytial virus bronchiolitis</article-title>
          <source>J Child Neurol</source>
          <year>2001</year>
          <volume>16</volume>
          <fpage>105</fpage>
          <lpage>108</lpage>
          <pub-id pub-id-type="pmid">11292214</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morichi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kawashima</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ioi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yamanaka</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Kashiwagi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Hoshika</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Classification of acute encephalopathy in respiratory syncytial virus infection</article-title>
          <source>J Infect Chemother</source>
          <year>2011</year>
          <volume>17</volume>
          <fpage>776</fpage>
          <lpage>781</lpage>
          <pub-id pub-id-type="doi">10.1007/s10156-011-0259-5</pub-id>
          <pub-id pub-id-type="pmid">21647570</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Otake</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yamagata</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Morimoto</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Imi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mori</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Aihara</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Elevated CSF IL-6 in a patient with respiratory syncytial virus encephalopathy</article-title>
          <source>Brain Dev</source>
          <year>2007</year>
          <volume>29</volume>
          <fpage>117</fpage>
          <lpage>120</lpage>
          <pub-id pub-id-type="doi">10.1016/j.braindev.2006.06.008</pub-id>
          <pub-id pub-id-type="pmid">16920309</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <mixed-citation publication-type="other">Kawashima H, Kashiwagi Y, Ioi H, Morichi S, Oana S, Yamanaka G, et al. Production of chemokines in respiratory syncytial virus infection with central nervous system manifestations. J Infect Chemother 2012 (in press)</mixed-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goldstein</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Giroir</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Randolph</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics</article-title>
          <source>Pediatr Crit Care Med</source>
          <year>2005</year>
          <volume>6</volume>
          <fpage>2</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1097/01.PCC.0000149131.72248.E6</pub-id>
          <pub-id pub-id-type="pmid">15636651</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Antonucci</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Chiappe</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Porcella</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rosatelli</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Fanos</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Bronchiolitis-associated encephalopathy in critically-ill infants: an underestimated complication?</article-title>
          <source>J Matern Fetal Neonatal Med</source>
          <year>2010</year>
          <volume>23</volume>
          <fpage>431</fpage>
          <lpage>436</lpage>
          <pub-id pub-id-type="doi">10.3109/14767050903184181</pub-id>
          <pub-id pub-id-type="pmid">19701864</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aiba</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Mochizuki</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kimura</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hojo</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Predictive value of serum interleukin-6 level in influenza virus-associated encephalopathy</article-title>
          <source>Neurology</source>
          <year>2001</year>
          <volume>57</volume>
          <fpage>295</fpage>
          <lpage>299</lpage>
          <pub-id pub-id-type="doi">10.1212/WNL.57.2.295</pub-id>
          <pub-id pub-id-type="pmid">11468315</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ichiyama</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Isumi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ozawa</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Matsubara</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Morishima</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Furukawa</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Cerebrospinal fluid and serum levels of cytokines and soluble tumor necrosis factor receptor in influenza virus-associated encephalopathy</article-title>
          <source>Scand J Infect Dis</source>
          <year>2003</year>
          <volume>35</volume>
          <fpage>59</fpage>
          <lpage>61</lpage>
          <pub-id pub-id-type="doi">10.1080/0036554021000026986</pub-id>
          <pub-id pub-id-type="pmid">12685886</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Herzum</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Renz</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Inflammatory markers in SIRS, sepsis and septic shock</article-title>
          <source>Curr Med Chem</source>
          <year>2008</year>
          <volume>15</volume>
          <fpage>581</fpage>
          <lpage>587</lpage>
          <pub-id pub-id-type="doi">10.2174/092986708783769704</pub-id>
          <pub-id pub-id-type="pmid">18336272</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nunoi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Mercado</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Mizukami</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Okajima</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Morishima</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Sakata</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Apoptosis under hypercytokinemia is a possible pathogenesis in influenza-associated encephalopathy</article-title>
          <source>Pediatr Int</source>
          <year>2005</year>
          <volume>47</volume>
          <fpage>175</fpage>
          <lpage>179</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1442-200x.2005.02042.x</pub-id>
          <pub-id pub-id-type="pmid">15771696</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kawashima</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ioi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ushio</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yamanaka</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Matsumoto</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nakayama</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Cerebrospinal fluid analysis in children with seizures from respiratory syncytial virus infection</article-title>
          <source>Scand J Infect Dis</source>
          <year>2009</year>
          <volume>41</volume>
          <fpage>228</fpage>
          <lpage>231</lpage>
          <pub-id pub-id-type="doi">10.1080/00365540802669543</pub-id>
          <pub-id pub-id-type="pmid">19117245</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eisenhut</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Cerebral involvement in respiratory syncytial virus disease</article-title>
          <source>Brain Dev</source>
          <year>2007</year>
          <volume>29</volume>
          <fpage>454</fpage>
          <pub-id pub-id-type="doi">10.1016/j.braindev.2006.11.007</pub-id>
          <pub-id pub-id-type="pmid">17174501</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Millichap</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Wainwright</surname>
              <given-names>MS</given-names>
            </name>
          </person-group>
          <article-title>Neurological complications of respiratory syncytial virus infection: case series and review of literature</article-title>
          <source>J Child Neurol</source>
          <year>2009</year>
          <volume>24</volume>
          <fpage>1499</fpage>
          <lpage>1503</lpage>
          <pub-id pub-id-type="doi">10.1177/0883073808331362</pub-id>
          <pub-id pub-id-type="pmid">19264736</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sakuma</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Sugai</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sasaki</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Acute nonparaneoplastic limbic encephalitis in childhood: a case series in Japan</article-title>
          <source>Pediatr Neurol</source>
          <year>2010</year>
          <volume>43</volume>
          <fpage>167</fpage>
          <lpage>172</lpage>
          <pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2010.04.012</pub-id>
          <pub-id pub-id-type="pmid">20691937</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>F&#xF6;rster</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Griebe</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gass</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kern</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Hennerici</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Szabo</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Diffusion-weighted imaging for the differential diagnosis of disorders affecting the hippocampus</article-title>
          <source>Cerebrovasc Dis</source>
          <year>2011</year>
          <volume>33</volume>
          <fpage>104</fpage>
          <lpage>115</lpage>
          <pub-id pub-id-type="doi">10.1159/000332036</pub-id>
          <pub-id pub-id-type="pmid">22179485</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hirayama</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sakazaki</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Murakami</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yonezawa</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fujimoto</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Seto</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Sequential MRI, SPECT and PET in respiratory syncytial virus encephalitis</article-title>
          <source>Pediatr Radiol</source>
          <year>1999</year>
          <volume>29</volume>
          <fpage>282</fpage>
          <lpage>286</lpage>
          <pub-id pub-id-type="doi">10.1007/s002470050589</pub-id>
          <pub-id pub-id-type="pmid">10199908</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
